March 19th, 2010
Podcast 79: Prostate cancer, patients’ consultations, and the treatments they receive
Podcast: Play in new window | Download
Subscribe: RSS
Patients who consult urologists only are more likely to get radical prostatectomy, and those who consult both urologists and radiation oncologists are more likely to get radiation. Those who see internists are more likely to receive watchful waiting. What are all these facts trying to tell us?
Our conversation is with the principal authors of a study of Medicare data that examines this issue.
This weeks interview-related link:
This week’s news-related links:
March 12th, 2010
Podcast 78: Just what are “comparative effectiveness” studies anyway?
Podcast: Play in new window | Download
Subscribe: RSS
This week, a conversation with Michael Hochman on his examination of what the major general journals publish in the way of comparative effectiveness studies. He talks about what they are and how to think about that reprint that the drug rep has just dropped off for you.
Reach us at 617-440-4374, or write to jelia@jwatch.org.
This week’s interview links:
This week’s news links:
March 5th, 2010
Podcast 77: We revisit a conversation on treating community-acquired pneumonia according to the guidelines (and we’ve got current news).
Podcast: Play in new window | Download
Subscribe: RSS
Our attempts to get an interview with a researcher were unavailing, so we’ve gone to plan B and repeat a useful look at treating community-acquired pneumonia according to guideline recommendations.
Please leave comments and complaints at jelia@jwatch.org. You can call and voice these at 1-617-440-4374.
Interview-related links:
News-related links:
February 27th, 2010
Podcast 76: On saying “No” to patients’ requests.
Podcast: Play in new window | Download
Subscribe: RSS
A conversation with the authors of an Archives of Internal Medicine study that examines the best tactics for saying “No” to inappropriate requests.
Contact me at 1-617-440-4374 or at jelia@jwatch.org.
Interview-related links:
News-related links:
February 19th, 2010
Podcast 75: Which regimen for hypertension?
Podcast: Play in new window | Download
Subscribe: RSS
Patients with hypertension at risk for cardiovascular events have done better with an ACE inhibitor-calcium channel blocker combination than with the ACE inhibitor plus hydrochlorothiazide. The ACCOMPLISH investigators have now reported on their analysis of progression-of-nephropathy outcomes in their trial. We interview the first author of the analysis, Dr. George Bakris of the University of Chicago’s Pritzker School of Medicine.
Interview-related links:
News-related links:
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
